CORE LABORATORIES INC (CLB) Fundamental Analysis & Valuation

NYSE:CLB • US21867A1051

Current stock price

16.21 USD
+0.24 (+1.5%)
At close:
15.89 USD
-0.32 (-1.97%)
After Hours:

This CLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CLB Profitability Analysis

1.1 Basic Checks

  • In the past year CLB was profitable.
  • CLB had a positive operating cash flow in the past year.
  • In the past 5 years CLB has always been profitable.
  • Each year in the past 5 years CLB had a positive operating cash flow.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • CLB's Return On Assets of 5.33% is fine compared to the rest of the industry. CLB outperforms 75.00% of its industry peers.
  • CLB's Return On Equity of 11.37% is fine compared to the rest of the industry. CLB outperforms 75.00% of its industry peers.
  • CLB has a Return On Invested Capital of 8.59%. This is in the better half of the industry: CLB outperforms 75.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLB is significantly below the industry average of 13.38%.
  • The 3 year average ROIC (8.28%) for CLB is below the current ROIC(8.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.33%
ROE 11.37%
ROIC 8.59%
ROA(3y)5.63%
ROA(5y)4.73%
ROE(3y)13.38%
ROE(5y)12.66%
ROIC(3y)8.28%
ROIC(5y)7.52%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • CLB has a better Profit Margin (6.04%) than 68.33% of its industry peers.
  • In the last couple of years the Profit Margin of CLB has grown nicely.
  • CLB has a Operating Margin (11.38%) which is in line with its industry peers.
  • CLB's Operating Margin has declined in the last couple of years.
  • CLB's Gross Margin of 20.69% is on the low side compared to the rest of the industry. CLB is outperformed by 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of CLB has declined.
Industry RankSector Rank
OM 11.38%
PM (TTM) 6.04%
GM 20.69%
OM growth 3Y6.08%
OM growth 5Y-2.63%
PM growth 3Y14.9%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CLB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
  • Compared to 1 year ago, CLB has less shares outstanding
  • The number of shares outstanding for CLB has been increased compared to 5 years ago.
  • Compared to 1 year ago, CLB has an improved debt to assets ratio.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • CLB has a debt to FCF ratio of 4.88. This is a neutral value as CLB would need 4.88 years to pay back of all of its debts.
  • CLB's Debt to FCF ratio of 4.88 is in line compared to the rest of the industry. CLB outperforms 51.67% of its industry peers.
  • CLB has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CLB (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.88
Altman-Z N/A
ROIC/WACC1.04
WACC8.28%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • CLB has a Current Ratio of 2.07. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
  • CLB's Current ratio of 2.07 is fine compared to the rest of the industry. CLB outperforms 61.67% of its industry peers.
  • CLB has a Quick Ratio of 1.57. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
  • CLB has a Quick ratio of 1.57. This is comparable to the rest of the industry: CLB outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.57
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CLB Growth Analysis

3.1 Past

  • CLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.64%.
  • Measured over the past years, CLB shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.77% on average per year.
  • CLB shows a small growth in Revenue. In the last year, the Revenue has grown by 0.51%.
  • Measured over the past years, CLB shows a small growth in Revenue. The Revenue has been growing by 1.56% on average per year.
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.48% on average over the next years. This is a very strong growth
  • CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.42% yearly.
EPS Next Y-0.77%
EPS Next 2Y2.53%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue Next Year-0.76%
Revenue Next 2Y-0.67%
Revenue Next 3Y5.44%
Revenue Next 5Y4.42%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. CLB Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.33, CLB is valued on the expensive side.
  • CLB's Price/Earnings ratio is a bit cheaper when compared to the industry. CLB is cheaper than 76.67% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CLB to the average of the S&P500 Index (25.23), we can say CLB is valued inline with the index average.
  • CLB is valuated rather expensively with a Price/Forward Earnings ratio of 21.49.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (22.42), we can say CLB is valued inline with the index average.
Industry RankSector Rank
PE 21.33
Fwd PE 21.49
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • CLB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CLB is more expensive than 70.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CLB is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 33.41
EV/EBITDA 11.3
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • CLB has a very decent profitability rating, which may justify a higher PE ratio.
  • CLB's earnings are expected to grow with 21.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.53%
EPS Next 3Y21.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CLB Dividend Analysis

5.1 Amount

  • CLB has a yearly dividend return of 0.25%, which is pretty low.
  • CLB's Dividend Yield is comparable with the industry average which is at 0.99.
  • Compared to an average S&P500 Dividend Yield of 1.89, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of CLB decreases each year by -32.16%.
  • CLB has paid a dividend for at least 10 years, which is a reliable track record.
  • CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-32.16%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 5.88% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.88%
EPS Next 2Y2.53%
EPS Next 3Y21.51%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CLB Fundamentals: All Metrics, Ratios and Statistics

CORE LABORATORIES INC

NYSE:CLB (3/20/2026, 8:04:00 PM)

After market: 15.89 -0.32 (-1.97%)

16.21

+0.24 (+1.5%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04
Earnings (Next)N/A
Inst Owners109.8%
Inst Owner Change-0.67%
Ins Owners1.26%
Ins Owner Change7.43%
Market Cap754.74M
Revenue(TTM)526.52M
Net Income(TTM)31.80M
Analysts48
Price Target16.15 (-0.37%)
Short Float %9.49%
Short Ratio11.11
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.04
Dividend Growth(5Y)-32.16%
DP5.88%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.53%
Min EPS beat(2)10.2%
Max EPS beat(2)12.86%
EPS beat(4)2
Avg EPS beat(4)4.52%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)5
Avg EPS beat(8)6.38%
EPS beat(12)7
Avg EPS beat(12)5.91%
EPS beat(16)9
Avg EPS beat(16)4.12%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)1.44%
Max Revenue beat(2)4.41%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.41%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)5
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)3.26%
EPS NQ rev (1m)-0.72%
EPS NQ rev (3m)31.43%
EPS NY rev (1m)-11.07%
EPS NY rev (3m)-9.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-4.73%
Revenue NY rev (3m)-4.73%
Valuation
Industry RankSector Rank
PE 21.33
Fwd PE 21.49
P/S 1.43
P/FCF 33.41
P/OCF 20.3
P/B 2.7
P/tB 12.8
EV/EBITDA 11.3
EPS(TTM)0.76
EY4.69%
EPS(NY)0.75
Fwd EY4.65%
FCF(TTM)0.49
FCFY2.99%
OCF(TTM)0.8
OCFY4.93%
SpS11.31
BVpS6.01
TBVpS1.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.14
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 11.37%
ROCE 12.23%
ROIC 8.59%
ROICexc 9.01%
ROICexgc 17.09%
OM 11.38%
PM (TTM) 6.04%
GM 20.69%
FCFM 4.29%
ROA(3y)5.63%
ROA(5y)4.73%
ROE(3y)13.38%
ROE(5y)12.66%
ROIC(3y)8.28%
ROIC(5y)7.52%
ROICexc(3y)8.61%
ROICexc(5y)7.81%
ROICexgc(3y)12.8%
ROICexgc(5y)11.12%
ROCE(3y)11.79%
ROCE(5y)10.71%
ROICexgc growth 3Y22.55%
ROICexgc growth 5Y6.53%
ROICexc growth 3Y8.12%
ROICexc growth 5Y-1.19%
OM growth 3Y6.08%
OM growth 5Y-2.63%
PM growth 3Y14.9%
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-2.17%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.88
Debt/EBITDA 1.48
Cap/Depr 99.59%
Cap/Sales 2.77%
Interest Coverage 250
Cash Conversion 49.87%
Profit Quality 71.02%
Current Ratio 2.07
Quick Ratio 1.57
Altman-Z N/A
F-Score7
WACC8.28%
ROIC/WACC1.04
Cap/Depr(3y)84.58%
Cap/Depr(5y)77.2%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.46%
Profit Quality(3y)82.62%
Profit Quality(5y)88.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.64%
EPS 3Y9.43%
EPS 5Y-0.77%
EPS Q2Q%-4.55%
EPS Next Y-0.77%
EPS Next 2Y2.53%
EPS Next 3Y21.51%
EPS Next 5Y20.48%
Revenue 1Y (TTM)0.51%
Revenue growth 3Y2.45%
Revenue growth 5Y1.56%
Sales Q2Q%6.98%
Revenue Next Year-0.76%
Revenue Next 2Y-0.67%
Revenue Next 3Y5.44%
Revenue Next 5Y4.42%
EBIT growth 1Y-1.42%
EBIT growth 3Y8.67%
EBIT growth 5Y-1.11%
EBIT Next Year33.61%
EBIT Next 3Y31.2%
EBIT Next 5Y23.36%
FCF growth 1Y-47.91%
FCF growth 3Y15.13%
FCF growth 5Y-13.26%
OCF growth 1Y-34.07%
OCF growth 3Y14.14%
OCF growth 5Y-8.48%

CORE LABORATORIES INC / CLB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?

ChartMill assigns a fundamental rating of 5 / 10 to CLB.


Can you provide the valuation status for CORE LABORATORIES INC?

ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.


Can you provide the profitability details for CORE LABORATORIES INC?

CORE LABORATORIES INC (CLB) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CLB stock?

The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 21.33 and the Price/Book (PB) ratio is 2.7.


What is the expected EPS growth for CORE LABORATORIES INC (CLB) stock?

The Earnings per Share (EPS) of CORE LABORATORIES INC (CLB) is expected to decline by -0.77% in the next year.